DOCS

DOXIMITY INC

Healthcare | Mid Cap

$0.20

EPS Forecast

$150.2

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-25

Doximity's Stellar Q4: Cash Flow and Revenue Surge Leave Competitors in the Dust

- By a Finance Enthusiast

Doximity, Inc. (NYSE: DOCS) has just shared its fourth quarter and fiscal year 2025 results, and let's just say, if you were looking for an earnings surprise, you got one. With total revenues of $138.3 million for Q4, up 17% year-over-year, and an impressive fiscal year revenue forecast of $570.4 million, up 20%, Doximity continues to establish itself as the go-to digital platform for U.S. medical professionals.

Q4 Highlights: Cash Flow and Earnings Galore

In addition to the revenue growth, Doximity reported an astounding operating cash flow of $98.5 million?up 54% year-over-year?and free cash flow of $97.0 million, a 56% increase. Not too shabby for a company that started as a simple networking tool for doctors.

What?s more, the company?s diluted EPS climbed to $0.31 from $0.20 last year, surpassing the EPS consensus expectations. Non-GAAP diluted EPS also saw growth, reaching $0.38, up from $0.25. This financial performance suggests that Doximity is not just surviving but thriving in a competitive landscape.

Fiscal Year 2025: A Year of Transformation

The year 2025 has proven to be transformative for Doximity. With total revenues climbing to $570.4 million?up from $475.4 million?the company's subscription revenue also saw a 21% increase, hitting $543.8 million. This growth trajectory is not merely a blip on the radar; it reflects a robust business model that resonates well with healthcare professionals seeking efficiency and connectivity.

Net income for the fiscal year soared to $223.2 million, compared to $147.6 million the previous year, representing a margin increase from 31.0% to 39.1%. Non-GAAP net income jumped to $286.1 million, solidifying Doximity's status as a profit powerhouse.

CEO Jeff Tangney's Vision: Engaging Doctors, Saving Time

CEO Jeff Tangney remarked, ?We closed out fiscal 2025 on a high note, with record engagement, strong profits, and 20% annual revenue growth.? The emphasis on record engagement is critical; in a world where healthcare professionals are inundated with information, Doximity's tools are clearly resonating. The company?s focus on AI-driven solutions is likely to further enhance its appeal, keeping doctors engaged and, importantly, saving them time.

Looking Ahead: What Does This Mean for Peers?

As Doximity continues to outperform expectations, competitors may find themselves under pressure to innovate quickly. With its robust revenue forecast and strong cash flow, Doximity is not merely a player in the healthcare tech space; it's setting the pace. For sector peers, the challenge will be to not only match these financial metrics but to also deliver solutions that cater to the evolving needs of healthcare professionals.

In summary, Doximity's latest earnings report is more than just numbers; it's a clear signal of its growth strategy paying off. As the digital landscape in healthcare continues to evolve, Doximity seems well-positioned to maintain its lead. The question is: can its rivals adapt fast enough, or will they end up as mere footnotes in the Doximity success story?